NANOBRICK, Expands Supply of Core Materials for Covid-19 Diagnosis Kits

-Rapid growth of diagnostic kit market due to the spread of novel coronavirus (COVID-19) worldwide

-Expansion of domestic and overseas supply of M-Bead, a core material for nucleic acid extraction, based on excellent quality and cost-effectiveness

NANOBRICK (KOSDAQ: 286750), a company specializing in new nanomaterials, is expanding the application of magnetic beads (M-Bead) for covid-19 molecular diagnostic kits, and has achieved a record high sales in the bio material business which are rapidly increasing.

Bio-refining material ‘M-Bead’ is a magnetic nanoparticle product coated with various functional groups, that can selectively and quickly separate/purify specific bio-materials using magnets. NANOBRICK is mass-producing M-Bead with uniform particle size and high quality based on the proven nano platform, and is expanding its supply to leading diagnostic kit companies domestically and overseas such as the United States and Canada.

M-Bead, a key reagent for nucleic acid extraction, which is very important for high-accuracy of early diagnosis of infection or disease, is characterized by excellent quality and price competitiveness based on a mass-produced quality system. M-Bead based nucleic acid extraction solutions are recognized for their excellent performance by automated diagnostic equipment manufacturers that require a large amount of nucleic acid extraction reagents.

NANOBRICK’s CEO Jae-Hyun Joo explained that, “With the prolonged covid-19 spread around the world, price competitiveness among diagnostic kit products are becoming more important with the explosive growth of the diagnostic kit market. Diagnostic kit companies have been customarily using expensive raw materials from famous manufacturers, but now they are demanding raw materials that can secure product with price competitiveness. I am quite confident that M-Bead of NANOBRICK, both fulfilling the high performance and cost competitiveness, is the best solution.” In addition, “As M-Bead has conducted rigorous performance tests with more than 20 diagnostic kit companies-domestic and overseas, and is proceeding supply contracts step by step from the second half of this year, sales in the bio material business are expected to grow rapidly in 2021.”

Meanwhile, according to a recent report by Markets and Markets, a global market analysis agency, the global diagnostic kit market is expected to grow from $5.5 billion in 2019 to $65.5 billion in 2023. The market of magnetic bead, used as consumables in the bio-pharmaceutical market, is expected to grow steadily from $0.755 billion in 2018 to $1.242 billion in 2023, with an average annual growth rate of 10.5%.

[Picture 1] Nucleic acid extraction using magnetic bead particles (M-Bead) among molecular diagnosis processes

[Photo 2] Core technology of M-Bead

[Picture 3] Product picture of M-Bead

[Photo 4] Microscopic photo of superparamagnetic nano particles, M-Bead